Crohn's disease. Achieving optimum health status.
Plante
Michelle L
ML
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003082:Colectomy; D003424:Crohn Disease / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D003937:Diagnosis, Differential; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006293:Health Promotion / Q000379:methods*; D006304:Health Status; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D009722:Nurse Practitioners; D024802:Nurse's Role; D010353:Patient Education as Topic; D011320:Primary Health Care / Q000379:methods; D011788:Quality of Life; D014481:United States / Q000453:epidemiology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab